ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
-5.4%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$111M
AUM Growth
+$111M
(+44%)
Cap. Flow
+$36.6M
Cap. Flow
% of AUM
32.88%
Top 10 Holdings %
Top 10 Hldgs %
57.45%
Holding
58
New
25
Increased
8
Reduced
9
Closed
12
Top Buys
| 1 |
BioMarin Pharmaceuticals
BMRN
|
$12M |
| 2 |
Thermo Fisher Scientific
TMO
|
$7.01M |
| 3 |
Bruker
BRKR
|
$5.98M |
| 4 |
Avantor
AVTR
|
$4.78M |
| 5 |
CONMED
CNMD
|
$4.23M |
Top Sells
| 1 |
Labcorp
LH
|
$7.86M |
| 2 |
Cigna
CI
|
$5.65M |
| 3 |
Agilent Technologies
A
|
$5.5M |
| 4 |
Becton Dickinson
BDX
|
$3.53M |
| 5 |
Cardinal Health
CAH
|
$3M |
Sector Composition
| 1 | Healthcare | 94.79% |
| 2 | Real Estate | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
BioMarin Pharmaceuticals
BMRN
$11.2B
| $15.9M | 14.27% | 179,568 +135,966 | +312% | +$12M |
|
|
2
Thermo Fisher Scientific
TMO
$186B
| $7.01M | 6.3% | +13,849 | New | +$7.01M |
|
|
3
Bruker
BRKR
$5.16B
| $6.93M | 6.23% | 111,276 +96,030 | +630% | +$5.98M |
|
4
AstraZeneca
AZN
$248B
| $6.53M | 5.87% | 96,444 +35,636 | +59% | +$2.41M |
|
5
Elevance Health
ELV
$71.8B
| $5.88M | 5.28% | 13,501 +7,865 | +140% | +$3.42M |
|
|
6
Avantor
AVTR
$9.18B
| $4.78M | 4.3% | +226,877 | New | +$4.78M |
|
7
Merck
MRK
$210B
| $4.57M | 4.1% | 44,384 -4,948 | -10% | -$509K |
|
8
argenx
ARGX
$43.6B
| $4.48M | 4.02% | 9,108 +6,543 | +255% | +$3.22M |
|
|
9
CONMED
CNMD
$1.68B
| $4.23M | 3.8% | +41,984 | New | +$4.23M |
|
10
Cooper Companies
COO
$13.4B
| $3.67M | 3.29% | +11,533 | New | +$3.67M |
|
11
Humana
HUM
$36.5B
| $3.2M | 2.88% | +6,584 | New | +$3.2M |
|
12
10x Genomics
TXG
$1.74B
| $2.93M | 2.63% | +71,044 | New | +$2.93M |
|
13
Sabra Healthcare REIT
SBRA
$4.58B
| $2.84M | 2.55% | +203,792 | New | +$2.84M |
|
14
Omega Healthcare
OHI
$12.6B
| $2.66M | 2.38% | +80,070 | New | +$2.66M |
|
15
Boston Scientific
BSX
$156B
| $2.53M | 2.27% | 47,893 -13,098 | -21% | -$692K |
|
16
OrthoPediatrics
KIDS
$536M
| $2.25M | 2.02% | 70,364 +59,623 | +555% | +$1.91M |
|
17
Cencora
COR
$56.5B
| $2.09M | 1.88% | +11,606 | New | +$2.09M |
|
18
Stryker
SYK
$150B
| $2.06M | 1.85% | +7,547 | New | +$2.06M |
|
19
Insmed
INSM
$28.8B
| $2.01M | 1.8% | 79,471 | – | – |
|
20
Zimmer Biomet
ZBH
$21B
| $1.96M | 1.76% | +17,479 | New | +$1.96M |
|
21
QuidelOrtho
QDEL
$1.95B
| $1.95M | 1.75% | +26,747 | New | +$1.95M |
|
22
DexCom
DXCM
$29.5B
| $1.93M | 1.73% | +20,694 | New | +$1.93M |
|
23
Tenet Healthcare
THC
$16.3B
| $1.79M | 1.61% | 27,151 -30,885 | -53% | -$2.04M |
|
24
Abbott
ABT
$231B
| $1.75M | 1.57% | +18,040 | New | +$1.75M |
|
|
25
Cigna
CI
$80.3B
| $1.74M | 1.56% | 6,083 -19,733 | -76% | -$5.65M |
|